Kelong Ma

2.3k total citations
42 papers, 1.2k citations indexed

About

Kelong Ma is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Kelong Ma has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Kelong Ma's work include Inflammatory Bowel Disease (8 papers), Epigenetics and DNA Methylation (7 papers) and Gut microbiota and health (6 papers). Kelong Ma is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Epigenetics and DNA Methylation (7 papers) and Gut microbiota and health (6 papers). Kelong Ma collaborates with scholars based in China, Australia and United States. Kelong Ma's co-authors include Jingde Zhu, Yinghua He, Hongyu Zhang, Hendrik G. Stunnenberg, Arie B. Brinkman, Anita Kaan, Femke Simmer, Jun Gu, Xiaoying Luo and Shicheng Guo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Kelong Ma

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelong Ma China 17 959 415 114 111 104 42 1.2k
Jinglun Xue China 20 983 1.0× 512 1.2× 256 2.2× 115 1.0× 84 0.8× 63 1.5k
C. Richard Boland United States 12 615 0.6× 318 0.8× 98 0.9× 165 1.5× 135 1.3× 28 1.1k
Jie Jiang China 19 670 0.7× 452 1.1× 42 0.4× 190 1.7× 105 1.0× 58 1.2k
Sarah P. Short United States 18 605 0.6× 176 0.4× 129 1.1× 251 2.3× 76 0.7× 45 1.2k
Lei Zhu China 18 609 0.6× 149 0.4× 245 2.1× 117 1.1× 78 0.8× 58 1.0k
Guowei Zuo China 24 869 0.9× 329 0.8× 33 0.3× 159 1.4× 60 0.6× 50 1.4k
Lesley A. Stark United Kingdom 15 473 0.5× 337 0.8× 99 0.9× 258 2.3× 79 0.8× 20 977
Qiu Du China 20 552 0.6× 261 0.6× 32 0.3× 61 0.5× 74 0.7× 44 976

Countries citing papers authored by Kelong Ma

Since Specialization
Citations

This map shows the geographic impact of Kelong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelong Ma more than expected).

Fields of papers citing papers by Kelong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelong Ma. The network helps show where Kelong Ma may publish in the future.

Co-authorship network of co-authors of Kelong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Kelong Ma. A scholar is included among the top collaborators of Kelong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelong Ma. Kelong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yibin, Hui Wu, Juan Sun, et al.. (2024). Effects of the N-Butanol Extract of Pulsatilla Decoction on Neutrophils in a Mouse Model of Ulcerative Colitis. Pharmaceuticals. 17(8). 1077–1077. 2 indexed citations
2.
Pan, Yang, et al.. (2024). Baicalin promotes β-1,3-glucan exposure in Candida albicans and enhances macrophage response. Frontiers in Cellular and Infection Microbiology. 14. 1487173–1487173. 1 indexed citations
3.
Zhang, Tengyue, et al.. (2023). Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studies. BMC Complementary Medicine and Therapies. 23(1). 152–152. 7 indexed citations
4.
Han, Zhijun, et al.. (2023). Cinnamaldehyde Ameliorates Dextran Sulfate Sodium‐Induced Colitis in Mice by Modulating TLR4/NF‐κB Signaling Pathway and NLRP3 Inflammasome Activation. Chemistry & Biodiversity. 20(2). e202200089–e202200089. 10 indexed citations
5.
Zhao, Ting, Kang Zhang, Gaoxiang Shi, et al.. (2022). Berberine Inhibits the Adhesion of Candida albicans to Vaginal Epithelial Cells. Frontiers in Pharmacology. 13. 814883–814883. 19 indexed citations
6.
Zhao, Liqiang, et al.. (2022). Comparative transcriptomic analysis reveals the regulatory mechanisms of catechins synthesis in different cultivars of Camellia sinensis. Food Research International. 157. 111375–111375. 13 indexed citations
8.
Ma, Kelong, Zhijun Han, Min Pan, et al.. (2020). [Therapeutic effect of cinnamaldehyde on ulcerative colitis in mice induced by dextran sulfate sodium with Candida albicans colonization and its effect on dectin-1/TLRs/NF-κB signaling pathway].. China Journal of Chinese Materia Medica. 45(13). 3211–3219. 2 indexed citations
9.
10.
11.
Qian, Liting, Kelong Ma, Tengyue Zhang, et al.. (2017). Evaluation of clinical efficacy after combinational treatment of esophageal cancer using target artery perfusion of verapamil and chemotherapy. Translational Cancer Research. 6(6). 1226–1235. 3 indexed citations
12.
Zhang, Tengyue, Kelong Ma, Jin Huang, et al.. (2017). CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma. Oncotarget. 8(66). 110052–110063. 10 indexed citations
13.
Ma, Kelong, Xiaorong Pan, Pingsheng Fan, et al.. (2014). Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells. Molecular Cancer. 13(1). 118–118. 62 indexed citations
14.
Ma, Kelong. (2013). Inhibitory Effects of Cepharanthine on Growth and Metastasis of Non-Small Cell Lung Cancer A549 Cells and Gene Expression of Heme Oxygenase-1 and Epidermal Growth Factor Receptor in A549 Cells. 1 indexed citations
15.
Zhao, Yangxing, Hua‐Fu Zhou, Kelong Ma, et al.. (2013). Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer. Oncology Letters. 5(4). 1211–1218. 38 indexed citations
16.
Huang, Jin, et al.. (2013). Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer. Cancer Chemotherapy and Pharmacology. 72(4). 889–896. 14 indexed citations
17.
Pirola, Luciano, Aneta Balcerczyk, Richard W. Tothill, et al.. (2011). Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Research. 21(10). 1601–1615. 162 indexed citations
19.
Yu, Wei, Chengmeng Jin, Xiaoyan Lou, et al.. (2011). Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell. PLoS ONE. 6(12). e29450–e29450. 54 indexed citations
20.
Brinkman, Arie B., Femke Simmer, Kelong Ma, et al.. (2010). Whole-genome DNA methylation profiling using MethylCap-seq. Methods. 52(3). 232–236. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026